In vivo–activated CD103(+)CD4(+) regulatory T cells ameliorate ongoing chronic graft-versus-host disease

CD103 (αEβ7) has been shown to be an excellent marker for identifying in vivo–activated FoxP3(+)CD4(+) regulatory T (Treg) cells. It is unknown whether reinfusion of in vivo–activated donor-type CD103(+) Treg cells from recipient can ameliorate ongoing chronic graft-versus-host disease (GVHD). Here,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhao, Dongchang, Zhang, Chunyan, Yi, Tangsheng, Lin, Chia-Lei, Todorov, Ivan, Kandeel, Fouad, Forman, Stephen, Zeng, Defu
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2518910/
https://ncbi.nlm.nih.gov/pubmed/18550852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140277
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados